In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.

In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. by Pfaller MA, Messer SA, Hollis RJ, Jones RN and Diekema DJ published in Antimicrob. Agents Chemother. 2002; 46 (6): 1723-1727